⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBX News
MBX Biosciences, Inc. Common Stock
Multibeam signe une lettre d’intention de 140 millions de dollars avec le département du Commerce des États-Unis
globenewswire.com
MBX
Attovia Therapeutics Appoints John W. Smither to Board of Directors
globenewswire.com
MBX
ARQT
NAMS
GNLX
Form 8-K
sec.gov
MBX
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
globenewswire.com
MBX
Form 8-K
sec.gov
MBX
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
globenewswire.com
MBX
Form 8-K
sec.gov
MBX
MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026
globenewswire.com
MBX
MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City
globenewswire.com
MBX
Form 8-K
sec.gov
MBX